Overview

Efficacy Study of Combined Treatment With Uric Acid and rtPA in Acute Ischemic Stroke

Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the combined treatment with Uric Acid and rtPA is superior to rtPA alone in terms of clinical efficacy in acute ischemic stroke patients treated within the first 4.5 hours of symptoms onset.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Angel Chamorro, MD
Collaborator:
Carlos III Health Institute
Treatments:
Lithium Carbonate
Mannitol
Uric Acid